Turner Construction has completed a five-storey, 311,881 sq ft outpatient oncology facility in Nashville, Tennessee. The project marks a roughly US$105 million build for Tennessee Oncology, delivering advanced cancer-care services under one roof. The development consolidates imaging, medical oncology, radiation and surgical oncology in a single building. Construction included three underground parking levels and a full interior build-out of tenant space. This facility reflects a growing trend toward outpatient specialist centres in the healthcare construction sector.
Design, Execution and Operational Features
The project incorporated three overlapping scopes: core and shell, full interior fit-out and a specialised drug-development unit. Turner’s team coordinated multiple trade partners and phased scheduling across design and construction to maintain alignment. The facility emphasises patient-centric design: integrated navigation, support services and streamlined oncology workflows. The underground parking and above-ground medical offices deliver convenience and accessibility for patients and staff alike. The build is part of a broader strategy by Tennessee Oncology to offer community-based high-quality cancer care near where people live and work.
Project Factsheet
Location: 322 22nd Ave. N., Nashville, Tennessee, USA
Size: 311,881 square feet
Storeys: 5 above ground + 3 underground parking levels
Cost: Approximately US$105 million
Developer/Client: Tennessee Oncology
General Contractor: Turner Construction Nashville office
Design/Engineering: Gresham Smith
Developer Partner: Johnson Healthcare Real Estate
Financing: Construction loan by Truist Bank (approx. US$98.3 m)
Key Services Housed: Imaging, infusion, medical, radiation, surgical oncology; nutrition and support services
Strategic importance: Centralises cancer-care operations in the Nashville market and supports clinical trials and research
Target completion: Facility opened in late 2025 for service delivery across Middle Tennessee.
Market Implications and Regional Significance
This development signals confidence in outpatient healthcare infrastructure even amid cautious construction markets. The medical office building (MOB) sector has faced subdued activity, yet this project demonstrates demand for advanced specialist care centres. The Nashville region benefits as one of the fastest-growing healthcare markets in the Southeast, with this build placing Tennessee Oncology and Turner Construction at the forefront. The facility’s consolidation of multiple specialties supports cost-effective care delivery while enhancing patient experience. From a construction industry viewpoint, the project showcases effective management of complex healthcare construction, balancing shell, fit-out and high-tech requirements.
Outlook and Strategic Takeaways
With full completion in late 2025, Tennessee Oncology’s centre is poised to elevate care delivery across Middle Tennessee. The facility’s integration of clinical, surgical, and research capabilities underscores how healthcare providers are moving toward one-stop campuses. For Turner Construction, this project adds to its healthcare portfolio at a time when managing complex outpatient builds demands specialised expertise. The case highlights that in healthcare real estate, investment continues even as broader commercial building remains uncertain. Similar momentum is seen in Georgia, where Wellstar Health has received approval for its $1 billion Acworth Hospital, as providers prioritise patient experience, operational efficiency, and innovation—driving the rise of purpose-built MOBs across the U.S.
